Patents by Inventor Gunjan Pramod Pathak

Gunjan Pramod Pathak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100081839
    Abstract: The present invention describes an improved industrial process for crystallizing out polymorph ‘Form I’ of (+) clopidogrel hydrogen sulphate (also called clopidogrel bisulphate) in) from either a Type-1 solvent or liquid characterized by comprising two or more functional groups or their mixtures thereof; or a Type-II solvent and/or solvent mixture selected from the group of methyl ethyl ketone, cyclopentylmethyl ether, dipropylglycolether, dibutylglycol ether, propylmethyl cellosolve, butylmethylcellosolve, propylethylellosolve, butylethylcellosolve or their cross combinations in a reproducible manner without detectable contamination of polymorph designated as ‘Form II’. The invention also discloses improvements in the preparation of clopidogrel free base and process for recovery and recycling of resolving agent camphor sulphonic acid.
    Type: Application
    Filed: July 24, 2009
    Publication date: April 1, 2010
    Applicant: IPCA Laboratories Ltd.
    Inventors: Ashok KUMAR, Priti Jayesh Bhayani, Vaibhav Chinubhai Doshi, Ashvini Saxena, Gunjan Pramod Pathak, Rashmi Abhyankar, Sarvanan Manavalan, Mukesh Purohit, Santosh Parihar
  • Patent number: 7470816
    Abstract: A process for the resolution of isomeric tramadol mixtures comprising: providing a purification stock comprising both cis and trans tramadol; contacting the purification stock with an acid under conditions effective to form an acid salt of the cis and trans tramadol in the purification stock; and separating the cis tramadol acid salt from the trans tramadol to obtain a purified cis tramadol acid salt; and optionally converting the cis tramadol acid salt to cis tramadol or to a pharmaceutically active salt thereof.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: December 30, 2008
    Assignee: IPAC Laboratories Limited
    Inventors: Ashok Kumar, Suneel Yeshwant Dike, Satish Rajanikant Soudagar, Chirag Hasmukh Shah, Sandeep Madhavrao Burudkar, Prashant Gautam, Byju Nellithanath Thankachen, Ashvini Saxena, Manavalan Saravanan, Gunjan Pramod Pathak, Virendra Pal, Rahul Karde, Jaysingh Gehlot
  • Publication number: 20080188663
    Abstract: The present invention describes an improved industrial process for crystallizing polymorph Form I of (+) clopidogrel hydrogen sulphate (also called clopidogrel bisulphate) in either a Type-I solvent or a Type-II. Type I solvent is an organic solvent containing two or more functional groups with a proviso that at least one functional group is different from the other(s). The Type II solvent is selected from methyl ethyl ketone, cyclopentylmethyl ether, dipropylglycolether, dibutylglycol ether, propylmethyl cellosolve, butylmethylcellosolve, propylethylellosolve, butylethylcellosolve or their cross combinations. The process produces Form I in a reproducible manner without detectable contamination of polymorph designated as Form II.
    Type: Application
    Filed: January 28, 2008
    Publication date: August 7, 2008
    Inventors: Ashok Kumar, Priti J. Bhayani, Vaibhav Chinubhai Doshi, Ashvini Saxena, Gunjan Pramod Pathak, Rashmi Abhyankar, Sarvanan Manavalan, Mukesh Purohit